125 related articles for article (PubMed ID: 38199422)
1. Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study.
Ran LY; Liu XY; Wang W; Tao WQ; Xiang JJ; Zeng Q; Kong YT; Zhang CY; Liao J; Qiu HT; Kuang L
J Affect Disord; 2024 Apr; 350():102-109. PubMed ID: 38199422
[TBL] [Abstract][Full Text] [Related]
2. Personality as a basis for antidepressant selection for patients with depression: A two-point outcome study at 4 and 8 weeks.
Naito M; Kato M; Koshikawa Y; Bandou H; Sakai S; Takekita Y; Nishida K; Kinoshita T
J Affect Disord; 2022 Oct; 314():27-33. PubMed ID: 35798178
[TBL] [Abstract][Full Text] [Related]
3. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
[TBL] [Abstract][Full Text] [Related]
4. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
[TBL] [Abstract][Full Text] [Related]
5. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
6. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
7. Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance.
Strawn JR; Aaronson ST; Elmaadawi AZ; Schrodt GR; Holbert RC; Verdoliva S; Heart K; Demitrack MA; Croarkin PE
J Child Adolesc Psychopharmacol; 2020 May; 30(4):261-266. PubMed ID: 32315537
[No Abstract] [Full Text] [Related]
8. Effects of Antidepressant Treatment on Symptom Measures of Attention in Adolescents with Depression: A Preliminary Open-Label Study.
Choi CH; Lee J; Lee KH; Hong SB; Kim SH; Han JY; Kim JW; Cho SC; Kim JW
J Child Adolesc Psychopharmacol; 2021 May; 31(4):288-293. PubMed ID: 33417814
[No Abstract] [Full Text] [Related]
9. Personality change during depression treatment: a placebo-controlled trial.
Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.
Knorr U; Vinberg M; Mortensen EL; Winkel P; Gluud C; Wetterslev J; Gether U; Kessing LV
PLoS One; 2012; 7(2):e31980. PubMed ID: 22393376
[TBL] [Abstract][Full Text] [Related]
11. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
12. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity.
Bagby RM; Levitan RD; Kennedy SH; Levitt AJ; Joffe RT
Psychiatry Res; 1999 Jun; 86(3):211-6. PubMed ID: 10482340
[TBL] [Abstract][Full Text] [Related]
13. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
14. Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents.
Lee KH; Shin J; Lee J; Yoo JH; Kim JW; Brent DA
JAMA Netw Open; 2023 Aug; 6(8):e2327331. PubMed ID: 37540512
[TBL] [Abstract][Full Text] [Related]
15. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
16. The influence of personality factors on paroxetine response time in patients with major depression.
Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
[TBL] [Abstract][Full Text] [Related]
17. Personality traits and escitalopram treatment outcome in major depression.
Aluoja A; Tõru I; Raag M; Eller T; Võhma Ü; Maron E
Nord J Psychiatry; 2018 Jul; 72(5):354-360. PubMed ID: 29688152
[TBL] [Abstract][Full Text] [Related]
18. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
[TBL] [Abstract][Full Text] [Related]
19. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
Kondo DG; Sung YH; Hellem TL; Fiedler KK; Shi X; Jeong EK; Renshaw PF
J Affect Disord; 2011 Dec; 135(1-3):354-61. PubMed ID: 21831448
[TBL] [Abstract][Full Text] [Related]
20. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
